Errors Lower Fee Award For Athira Pharma Investors' Counsel

By Emily Sawicki · November 4, 2024, 7:40 PM EST

A Seattle federal judge has awarded $2 million in attorney fees to four firms that represented a class of Athira Pharma investors following a $10 million settlement over allegations the company's...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

Nacif et al v. Athira Pharma Inc et al

Case Number

Court

Washington Western

Nature of Suit

Securities/Commodities

Date Filed

June 25, 2021

Recent Articles By Emily

December 02, 2024
NJ Siblings Say Fox Rothschild Must Face Malpractice Suit
November 26, 2024
Armstrong Teasdale Grows In Big Apple With New IP Partner
November 06, 2024
Gordon Rees Unveils Silicon Valley Office, Its 11th In Calif.
November 05, 2024
Lab Owner's Atty DQ'd After Repping Doctor In Fraud Inquiry
October 11, 2024
Fox Rothschild Aims To Exit Malpractice Suit Over Land Row
August 28, 2024
NJ Health System Repeats Call For Proskauer DQ
August 22, 2024
DLA Piper Wants Texas High Court To Review Doc Order
August 21, 2024
9th Circ. Lets Atty Fight Against $8M Malicious Prosecution
August 21, 2024
NJ Health System Calls Proskauer DQ Bid A 'Litigation Tactic'
July 31, 2024
Fox Rothschild Faces Malpractice Suit Over Land Row